Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?

Szolnoky, Gyozo; González-Ochoa, Alejandro José

Szolnoky, Gyozo; González-Ochoa, Alejandro José.

Szolnoky G; Department of Dermatology and Allergology, 37443University of Szeged, Korányi fasor 6, H-6720 Szeged, Hungary.
González-Ochoa AJ; Department of Vascular-Endovascular Surgery, CLINEDEM, callejón 5 de mayo y calle 7 No 791, Colonia Comercial, 83449 San Luis Rio Colorado, Sonora, México.

Clin Appl Thromb Hemost ; 28: 10760296221084300, 2022.

Article in English | MEDLINE | ID: covidwho-1765359

Subject(s)

COVID-19 Drug Treatment; COVID-19; COVID-19/complications; Disease Progression; Glycosaminoglycans; Humans; Post-Acute COVID-19 Syndrome

Keywords

COVID-19; anticoagulants; endothelial dysfunction; sulodexide

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / COVID-19 Drug Treatment Topics: Long Covid Limits: Humans Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: 10760296221084300

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google